Key points from article :
Semma Therapeutics is looking to use stem cells to regulate blood sugar level.
For some type 1 diabetes patients the condition is caused when body mistakenly kills beta cells found in the pancreas.
Embryonic stem cells are grown into beta cells.
Delivered via implant under a patient's skin.
